Genetically modified mouse models show that the deletion of FIP200 can inhibit autophagy and decrease the Tim4+ Tumor-associated macrophage population, consequently promoting the antitumor activity of T-cells [149]. This evidence concerns the gene TIMD4 and neoplasm.